Doctors Petri and Kahlenberg are names the 2018 recipients of the Evelyn V. Hess Award and Mary Betty Stevens Young Investigator Prize.
Exagen Diagnostic, creator of the AVISE® CTD test for lupus, expands portfolio of patented CB-CAPs blood tests.
Awardee research areas underline breadth of field and comprehensive approach to studying lupus.
CEO Sandra C. Raymond responds to announcement of Phase III trial results of anifrolumab.
Exagen Diagnostics and CareFirst BlueCross have come together for the new lupus diagnostic test.
Grant awardees focus on moving research forward in two critical areas, childhood lupus and kidney damage
The LFA, in partnership with NIAD, will co-fund a study researching potential new lupus treatments.
A diagnostic test developed through research supported by the Foundation has found to be a reliable measure of lupus disease activity.